Low-dose aspirin may limit cancer metastasis by inhibiting platelet activation and enhancing T-cell immunity, supporting biomarker guided use while balancing bleeding risk overall.

An international research team headed by scientists at the University of Cambridge has uncovered a mechanism that may underpin how aspirin could reduce the metastasis of some cancers by preventing an ...

Long-term daily use of aspirin can help to prevent the development and progression of colorectal cancer (CRC) but the mechanisms involved have been unclear. New research headed by investigators at the ...